Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
45.14 USD | -4.18% | -3.96% | -10.77% |
Sales 2024 * | 599M 49.99B | Sales 2025 * | 765M 63.9B | Capitalization | 6.58B 550B |
---|---|---|---|---|---|
Net income 2024 * | -572M -47.76B | Net income 2025 * | -519M -43.33B | EV / Sales 2024 * | 10.6 x |
Net cash position 2024 * | 219M 18.32B | Net Debt 2025 * | 212M 17.7B | EV / Sales 2025 * | 8.88 x |
P/E ratio 2024 * |
-11.9
x | P/E ratio 2025 * |
-13.7
x | Employees | 927 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.17% |
Latest transcript on Ionis Pharmaceuticals, Inc.
1 day | -4.18% | ||
1 week | -3.96% | ||
Current month | -5.29% | ||
1 month | +20.15% | ||
3 months | +4.98% | ||
6 months | -14.62% | ||
Current year | -10.77% |
Managers | Title | Age | Since |
---|---|---|---|
D. Walke
FOU | Founder | 58 | 01/12/01 |
Brett Monia
FOU | Founder | 62 | 10/89/10 |
Elizabeth Hougen
DFI | Director of Finance/CFO | 62 | 01/00/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Joseph Loscalzo
CHM | Chairman | 72 | 03/14/03 |
Brett Monia
FOU | Founder | 62 | 10/89/10 |
Joan Herman
BRD | Director/Board Member | 70 | 10/19/10 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
6.89% | 1 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
02/24/02 | 45.14 | -4.18% | 1,720,305 |
01/24/01 | 47.11 | -1.15% | 2,448,592 |
28/24/28 | 47.66 | +0.91% | 2,626,198 |
27/24/27 | 47.23 | -0.99% | 1,982,856 |
26/24/26 | 47.7 | +1.49% | 2,531,312 |
Delayed Quote Nasdaq, July 03, 2024 at 01:30 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.77% | 6.58B | |
+17.72% | 44.87B | |
-10.33% | 37.8B | |
+37.55% | 37.61B | |
+29.36% | 31.32B | |
-8.44% | 27.4B | |
+12.45% | 26.32B | |
+44.19% | 14.07B | |
+31.93% | 12.5B | |
-7.67% | 11.23B |
- Stock Market
- Equities
- IONS Stock